Disseminated Intravascular Coagulation (DIC) Market Trends 2025-2034: Insights into Growth and Strategic Opportunities Ahead
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Disseminated Intravascular Coagulation (DIC) Market’s Growth Rate Evolve Over the Forecast Period to 2034?
In recent times, the market size for disseminated intravascular coagulation (DIC) has experienced considerable growth. It is projected to rise from a worth of $0.46 billion in 2024 to reach $0.49 billion in 2025, having a compound annual growth rate (CAGR) of 5.3%. The growth seen in the historical period can be linked to an increased occurrence of sepsis, a rise in trauma cases, a surge in the incidence of cancer, amplified spending in healthcare, improved awareness in healthcare professionals, and an increased adoption of targeted therapies.
The market for disseminated intravascular coagulation (DIC) is forecasted to experience substantial growth in the upcoming years, expanding to a value of $0.59 billion by 2029 with a compound annual growth rate (CAGR) of 5.0%. This predicted growth throughout the forecast period can be credited to factors such as the rising popularity of targeted therapies, a greater emphasis on early detection of diseases, increased investment in healthcare infrastructure, the broadening scope of clinical research into treatments for coagulopathy, and an increase in understanding of uncommon hematologic disorders. Noteworthy trends projected for this period include advancements in diagnostic tests, the embracing of new anticoagulant treatments, personalized treatment strategies, the use of AI in diagnostic procedures, upgraded patient monitoring technologies, and the progression of targeted therapies.
Which Macro and Microeconomic Factors Are Accelerating the Growth of the Disseminated Intravascular Coagulation (DIC) Market?
Anticipated growth in the disseminated intravascular coagulation (DIC) market is predicted to be driven by the rising incidence of cancer. Uncontrolled and abnormal cell growth and proliferation characterize cancer, leading to the invasion and demolition of normal body tissues. The escalation in the number of cancer cases can be attributed to factors such as aging populations, alterations in lifestyle, environmental factors, infections, and genetic susceptibilities. Disseminated intravascular coagulation in cancer patients is caused by the over-activation of the coagulation cascade due to cancerous tumour-associated pro-coagulant substances, which results in extensive clotting and bleeding. As per the National Cancer Institute, a US government agency, they reported approximately 20 million new cancer cases and 9.7 million fatal incidences related to cancer globally in 2022. It is projected that by 2040, these figures could escalate to 29.9 million new cancer cases and 15.3 million death occurrences each year. Therefore, the growth of the disseminated intravascular coagulation (DIC) market is driven by the escalating rate of cancer incidents.
Get Your Free Sample of the Global Disseminated Intravascular Coagulation (DIC) Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21172&type=smp
Who Are the Influential Players Reshaping the Disseminated Intravascular Coagulation (DIC) Market Landscape?
Major companies operating in the disseminated intravascular coagulation (DIC) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Danaher Corporation, Eli Lily and Company, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., Mylan N.V., Grifols S.A., Eisai Co. Ltd., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc.
What New and Evolving Trends Are Having a Lasting Impact on the Disseminated Intravascular Coagulation (DIC) Market?
Leading corporations in the disseminated intravascular coagulation (DIC) market are concentrating on evolving coagulation diagnostic technology, including next-generation clotting tests. These advancements aim to refine the precision, speed, and simplicity of DIC diagnosis, thereby facilitating quicker therapeutic interventions for better patient outcomes. Next-generation clotting tests are innovative diagnostic tools and methods devised to measure blood coagulation more effectively, rapidly, and thoroughly compared to conventional tests. For example, in June 2022, LumiraDx Limited, a healthcare company based in the UK, broadened its cardiovascular testing range by obtaining CE Mark approvals for its updated D-dimer tests and NT-proBNP. These tests heighten the LumiraDx Platform’s capacity to aid clinicians in the diagnosis of heart failure and the exclusion of venous thromboembolisms at the care point. These enhancements aim to boost early detection and management of cardiovascular and thrombotic conditions, including DIC.
Get Instant Access to the Global Disseminated Intravascular Coagulation (DIC) Market Report with Swift Delivery!
Which Key Segments Stand Out in Understanding the Composition of the Disseminated Intravascular Coagulation (DIC) Market?
The disseminated intravascular coagulation (DIC) market covered in this report is segmented –
1) By Treatment: Medicines, Transfusions, Surgery, Other Treatments
2) By Diagnosis: Complete Blood Count With Blood Smear Exam, Partial Thromboplastin Time (PTT), Fibrinogen Blood Test, D-dimer, Other Diagnoses
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Medicines: Anticoagulants, Antiplatelet Drugs, Fibrinolytics, Procoagulants, Antithrombin Therapy
2) By Transfusions: Platelet Transfusion, Fresh Frozen Plasma (FFP), Cryoprecipitate Transfusion, Red Blood Cell Transfusion
3) By Surgery: Surgical Removal Of Thrombus, Organ Surgery
4) By Other Treatments: Plasma Exchange, Supportive Care, Steroid Therapy
Which Geographic Locations Are Critical to the Growth of the Disseminated Intravascular Coagulation (DIC) Market?
North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in the disseminated intravascular coagulation (DIC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Characteristics That Define the Disseminated Intravascular Coagulation (DIC) Market?
Disseminated intravascular coagulation (DIC) is a complex, life-threatening condition characterized by excessive blood clotting followed by severe bleeding due to the depletion of clotting factors and platelets. It is triggered by underlying conditions such as sepsis, trauma, malignancies, and obstetric complications.
Browse Through More Similar Reports By The Business Research Company:
Severe Acute Respiratory-Syndrome Treatment Global Market Report 2025
Myelodysplastic Syndrome (MDS) Drugs Global Market Report 2025
Hospital-Acquired Infection Control Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
